Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction

Internal and Emergency Medicine

Volumn 7, Issue SUPPL. 2, 2012, Pages 77-79

  Vultaggio, Alessandra ^a   Matucci, Andrea ^a   Nencini, Francesca ^b   Pratesi, Sara ^b   Maggi, Enrico ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN E; INFLIXIMAB; MONOCLONAL ANTIBODY;

ADULT; BEHCET DISEASE; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; RHEUMATOID ARTHRITIS; SKIN TEST;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFUSIONS, INTRAVENOUS; MALE; SKIN TESTS;

EID: 84865704139     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0611-x     Document Type: Letter

References (5)

1. Khan DA, Solensky R (2010) Drug allergy. J Allergy Clin Immunol 125: S126-S137.
2. Wiens A, Venson R, Correr CJ, Otuki MF, Pontarolo R (2010) Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis. Pharmacotherapy 30: 339-353.
3. Maggi E, Vultaggio A, Matucci A (2011) Acute infusion reactions during monoclonal antibody therapy. Expert Rev Clin Immunol 7: 55-63.
4. Vultaggio A, Matucci A, Nencini F, Pratesi S, Parronchi P, Rossi O, Romagnani S, Maggi E (2010) Anti-infliximab IgE and non IgE antibodies and induction of infusion-related severe anaphylactic reactions. Allergy 65: 657-661.
5. Aarden L, Ruuls SR, Wolbink G (2008) Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti antibody measurement. Curr Opin Immunol 20: 431-435.